CSTL
Castle Biosciences, Inc.
24.49
1 x 17.80
1 x 24.74
bid
ask
-
0.22
0.88%
10:19 AM
timesize
| Ytd | -37.04% | |
| 1y | 22.40% |
24.40
day range
24.98
14.59
52 week range
44.28
| Open | 24.71 | Prev Close | 24.71 | Low | 24.40 | High | 24.98 | Mkt Cap | 742.02M |
| Vol | 19.15K | Avg Vol | 401.42K | EPS | -0.42 | P/E | N/A | Forward P/E | -13.54 |
| Beta | 0.98 | Short Ratio | 4.27 | Inst. Own | 94.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 21.74 | 200-d Avg | 28.70 | 1yr Est | 41.56 |
| Income Statement | |||
| Total Revenue | 83.68M | ||
| Revenues (USD) | 83.68M | ||
| Cost of Revenue | 20.53M | ||
| Gross Profit | 63.15M | ||
| Operating Expenses | 81.55M | ||
| Research and Development Expense | 14.43M | ||
| Selling, General and Administrative Expense | 64.90M | ||
| Operating Income | -18.41M | ||
| Interest Expense | 134.00K | ||
| Income Tax Expense | 109.00K | ||
| Net Income | -14.52M | ||
| Net Income Common Stock | -14.52M | ||
| Net Income Common Stock (USD) | -14.52M | ||
| Consolidated Income | -14.52M | ||
| Earnings per Basic Share | -0.49 | ||
| Earnings per Basic Share (USD) | -0.49 | ||
| Earnings per Diluted Share | -0.49 | ||
| Earning Before Interest & Taxes (EBIT) | -14.28M | ||
| Earning Before Interest & Taxes (USD) | -14.28M | ||
| Weighted Average Shares | 29.89M | ||
| Weighted Average Shares Diluted | 29.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 63.76M | ||
| Cash and Equivalents (USD) | 63.76M | ||
| Investments | 197.92M | ||
| Investments Current | 197.92M | ||
| Trade and Non-Trade Receivables | 44.19M | ||
| Current Assets | 328.90M | ||
| Property, Plant & Equipment Net | 115.36M | ||
| Total Assets | 547.80M | ||
| Debt Current | 2.92M | ||
| Total Debt | 36.72M | ||
| Current Liabilities | 48.76M | ||
| Debt Non-Current | 33.80M | ||
| Total Liabilities | 86.39M | ||
| Accumulated Retained Earnings (Deficit) | -238.81M | ||
| Accumulated Other Comprehensive Income | -63.00K | ||
| Shareholders Equity | 461.42M | ||
| Shareholders Equity (USD) | 461.42M | ||
| Assets Non-Current | 218.90M | ||
| Total Debt (USD) | 36.72M | ||
| Goodwill and Intangible Assets | 97.35M | ||
| Inventory | 10.46M | ||
| Liabilities Non-Current | 37.63M | ||
| Trade and Non-Trade Payables | 15.04M | ||
| Tax Liabilities | 2.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.93M | ||
| Net Cash Flow from Financing | -5.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -52.96M | ||
| Capital Expenditure | -12.45M | ||
| Issuance (Purchase) of Equity Shares | 1.59M | ||
| Issuance (Repayment) of Debt Securities | -24.00K | ||
| Net Cash Flow from Investing | -25.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -13.35M | ||
| Net Cash Flow from Operations | -22.13M | ||
| Share Based Compensation | 9.78M | ||